Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 • July 07, 2021 • 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: How Biotech Gets Built
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 35

November 14, 2023 • 00:44:55
Episode Cover

Episode 35: Charlene Son Rigby, CEO at Global Genes

"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...

Listen

Episode 53

April 29, 2025 • 00:50:46
Episode Cover

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...

Listen

Episode 64

November 11, 2025 • 00:47:30
Episode Cover

Video Episode 64 - Professor Justin Stebbing

Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris...

Listen